News
Vinay Prasad, M.D., has left the FDA less than three months into the role as director of the Center for Biologics Evaluation ...
Vinay Prasad, a top regulator at the US Food and Drug Administration, left the agency after a short-lived tenure that ended ...
The immediate ebullient reaction to Vinay Prasad’s ouster is understandable, and may ultimately be the correct one, Adam ...
2don MSN
Dr Vinay Prasad, the FDA's Chief Medical and Scientific Officer, resigned from his post on 29 July 2025 after mounting ...
Vinay Prasad was supposed to be the guy who kept Big Pharma in check. Now he’s gone.
Sources also say that the administration plans to split CBER in two, with one of the section focused entirely on vaccines.
Prasad came to the Food & Drug Administration in May, hoping to set high, evidence-based standards for new medicines. He didn't even last three months. The industry's power has never been clearer.
But this time, the unknown is hitting the industry in a different way from when Prasad was tapped to lead CBER less than ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results